Clinical Trial Update: Study of Teriparatide in the Treatment of Postmenopausal Women With Osteoporosis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating teriparatide for postmenopausal osteoporosis has completed. The study was sponsored by Eli Lilly and Company.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis
• Postmenopausal Osteoporosis

Drugs mentioned

• Forteo (teriparatide)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Osteoporosis, Post-Menopausal | Phase 3 | Status: COMPLETED